1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
(
- Contribution to journal › Article
-
Mark
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
(
- Contribution to journal › Article
- 2019
-
Mark
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival : an epigenomic–smoking interaction analysis
(
- Contribution to journal › Article
-
Mark
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
(
- Contribution to journal › Article
- 2018
-
Mark
DNA Methylation of LRRC3B : A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients
2018) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27(12). p.1527-1535(
- Contribution to journal › Article
-
Mark
A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Epigenetic modifications inlysine demethylases associate with survival of early-stage NSCLC
(
- Contribution to journal › Article